Preferred Name |
tesamorelin |
|
Synonyms |
TH9507 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C479538 |
|
altLabel |
TH9507 TH-9507 egrifta |
|
cui |
C1313807 C2961776 C1876200 |
|
Has mapping qualifier | ||
HM |
D013007/Q000031 |
|
II |
D008060 |
|
Inverse of RB |
MQG94M5EEO 0 |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
20031211 |
|
MeSH Frequency |
67 |
|
MMR |
20170727 |
|
notation |
C479538 |
|
PA |
D006133 |
|
PI |
*PEPTIDES (2003-2007) |
|
prefLabel |
tesamorelin |
|
SC |
1 |
|
Scope Statement |
a peptide; a stabilized analogue of the growth hormone releasing factor; aimed at reducing excess abdominal fat or VAT in lipodystrophy and HIV patients |
|
SRC |
AIDS Patient Care STDS. 2003 Sep;17(9):489 |
|
TERMUI |
T562791 T687624 T562792 T787081 |
|
TH |
FDA SRS (2017) USAN (19XX) INN (19XX) NLM (2003) NLM (2006) NLM (2011) |
|
tui |
T125 T116 T121 |
Create mapping